Art

J-GLOBAL ID：200902216106647628   Reference number：06A0533740

Safety and Efficacy of Low-dose Pioglitazone (7.5 mg/day) vs. Standard-dose Pioglitazone (15 mg/day) in Japanese Women with Type 2 Diabetes Mellitus

日本人女性2型糖尿病での低用量ピオグリタゾン(7.5mg/日)と標準用量ピオグリタゾン(15mg/日)の安全性と有効性

Author (9)： MAJIMA Takafumi (Dep. of Endocrinology and Metabolism, Rakuwakai Otowa Hospital) ,  MAJIMA Takafumi (Dep. of Medicine and Clinical Sci., Kyoto Univ. Graduate School of Medicine) ,  KOMATSU Yasato (Dep. of Medicine and Clinical Sci., Kyoto Univ. Graduate School of Medicine) ,  DOI Kentaro (Dep. of Endocrinology and Metabolism, Rakuwakai Otowa Hospital) ,  SHIGEMOTO Michika (Dep. of Endocrinology and Metabolism, Rakuwakai Otowa Hospital) ,  TAKAGI Chieko (Dep. of Endocrinology and Metabolism, Rakuwakai Otowa Hospital) ,  FUKAO Atsushi (Dep. of Psychosomatic Medicine, Rakuwakai Otowa Hospital) ,  CORNERS Jerry (Medical Adviser, Rakuwakai Otowa Hospital) ,  NAKAO Kazuwa (Dep. of Medicine and Clinical Sci., Kyoto Univ. Graduate School of Medicine)
Material： Endocrine Journal  (Endocr J)
Volume： 53  Issue： 3  Page： 325-330 (J-STAGE)  Publication year： 2006 
JST Material Number： F0625A  ISSN： 0918-8959  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： non-insulin-dependent diabetes mellitus ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=06A0533740&from=J-GLOBAL&jstjournalNo=F0625A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for endocrine diseases  (GL05020S)

Substance index (1)： Pioglitazone

Reference (26)：

• INZUCCHI, SE. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med. 1998, 338, 867-872
• PARULKAR, AA. Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med. 2001, 134, 61-71
• STUMVOLL, M. Glitazones : clinical effects and molecular mechanisms. Ann Med. 2002, 34, 217-224
• O'MOORE-SULLIVAN, TM. Thiazolidinediones and type 2 diabetes : new drugs for an old disease. Med J Aust. 2002, 176, 381-386
• EDELMAN, SV. The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors. Rev Cardiovasc Med. 2003, 4, S29-S37

Terms in the title (9)： 日本人 ,  女性 ,  2型糖尿病 ,  低用量 ,  ピオグリタゾン ,  標準 ,  用量 ,  安全性 ,  有効性